Intervention

Tinzaparin

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions10

Lead sponsors shown4

Clinical trials

4 shown

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia PreventionNCT07361679 · 2023-01-18

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous ThromboembolismNCT03240120 · 2017-09-01

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)NCT03099031 · 2015-05-01

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon CancerNCT00967148 · 2009-06-01

Common conditions

Deep Vein Thrombosis2 Pulmonary Embolism2 Venous Thromboembolism2 Cancer1 Gestational Hypertension1 Hypertension, Pregnancy-Induced1 Preeclampsia1 Preeclampsia Severe1 Pregnancy Complications1 Toxemia Of Pregnancy1

Leading sponsors

Alexandra Hospital, Athens, Greece1 LEO Pharma1 Ottawa Hospital Research Institute1 The University of Hong Kong1

Trial status mix

COMPLETED2

RECRUITING1

UNKNOWN1

Phase mix

NA1

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.